|
受注：045-509-1970 |
技術サポート：[email protected] 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
Befovacimab (Anti-TFPI)
製品コード：A2779 Batch: A277901
Befovacimab (anti-TFPI) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitors (TFPI) with the potential to be used in haemophilia A/B research. MW: 143.24 kD.
製品説明
| CAS No. | 2156634-62-5 |
|---|---|
| Formulation | 100mMPro-Ac,20mMArg-Ac，pH5.0 |
| Isotype | Human IgG2SA |
| Source | CHO |
| Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
| Shipping | Shipped under low temperature conditions |
| Purity | 99% |
| Protein concentration | 6.442mg/ml |
| Endotoxin Level | ＜1EU/mg |
人間や獣医の診断であるか治療的な使用のためにでない。